Monday July 27, 2026 1:05 PM ET

Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels

Monday July 20, 2026 3:46 PM ET

Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units

Friday July 17, 2026 2:55 PM ET

Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases

Thursday July 16, 2026 1:15 PM ET

Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases

Wednesday July 15, 2026 2:15 PM ET

Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases

Tuesday July 14, 2026 2:40 PM ET

Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases

Monday July 13, 2026 3:00 PM ET

Cosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market Repurchases

Monday July 13, 2026 1:00 PM ET

Cosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in Greece

Friday July 10, 2026 10:55 AM ET

Cosmos Health Launches Subscription Model

Thursday July 9, 2026 3:45 PM ET

Cosmos Health Expands Share Buyback to 4.14 Million Shares; Continues Open Market Repurchases

Wednesday July 8, 2026 3:40 PM ET

Cosmos Health Share Buyback Surpasses 4 Million Shares; Continues Open Market Repurchases

Tuesday July 7, 2026 9:29 AM ET

Cosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share Repurchases

Monday July 6, 2026 2:30 PM ET

Cosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market Purchases

Thursday July 2, 2026 2:10 PM ET

Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases

Wednesday July 1, 2026 11:05 AM ET

Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace

Tuesday June 30, 2026 11:55 AM ET

Cosmos Health Authorizes Up to $5 Million Share Repurchase Program

Friday June 26, 2026 12:30 PM ET

Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units

Wednesday June 24, 2026 3:37 PM ET

Cosmos Health’s C-Sept PRO Gains Strong Traction Across Leading Greek Public and Private Hospital Groups, With Annualized Sales Poised to Exceed $1.3 Million at Approximately 72% Gross Margin

Tuesday June 23, 2026 3:35 PM ET

Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency

Thursday June 18, 2026 3:34 PM ET

CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity

Wednesday June 17, 2026 3:35 PM ET

Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States

Wednesday June 17, 2026 9:27 AM ET

Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products

Monday June 15, 2026 9:00 AM ET

Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit

Friday June 12, 2026 3:33 PM ET

Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines

Friday June 12, 2026 9:29 AM ET

Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit

Thursday June 11, 2026 3:31 PM ET

Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio

Thursday June 11, 2026 9:35 AM ET

Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance

Wednesday June 10, 2026 3:32 PM ET

Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries

Wednesday June 10, 2026 9:00 AM ET

Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway

Friday June 5, 2026 9:25 AM ET

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories

Thursday June 4, 2026 3:57 PM ET

Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz

Thursday June 4, 2026 9:25 AM ET

Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value

Tuesday June 2, 2026 8:00 AM ET

Cosmos Health Provides Balance Sheet Update: Highlights European Investment Bank Financing Discussions for up to €25M, Eliminates 38% of Warrant Overhang with No Dilution; Reaffirms Growth Trajectory; Notes No Known Business Reason for Recent Share Price

Monday June 1, 2026 8:25 AM ET

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

Tuesday May 26, 2026 9:34 AM ET

Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 — Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation

Thursday March 19, 2026 12:45 PM ET

Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Projected

Tuesday March 10, 2026 9:00 AM ET

Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000